Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes

Kousuke Noda, shintaro nakao, Souska Zandi, Verena Engelstädter, Yukihiko Mashima, Ali Hafezi-Moghadam

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

Vascular adhesion protein-1 (VAP-1) is an endothelial adhesion molecule that possesses semicarbazide-sensitive amine oxidase (SSAO) activity and is involved in leukocyte recruitment. Leukocyte adhesion to retinal vessels is a predominant feature of experimentally induced diabetic retinopathy (DR). However, the role of VAP-1 in this process is unknown. Diabetes was induced by i.p. injection of Streptozotocin in Long-Evans rats. The specific inhibitor of VAP-1, UV-002, was administered by daily i.p. injections. The expression of VAP-1 mRNA in the retinal extracts of normal and diabetic animals was measured by real-time quantitative polymerase chain reaction (PCR). Firm leukocyte adhesion was quantified in retinal flatmounts after intravascular staining with concanavalin A (ConA). Leukocyte transmigration rate was quantified by in vivo acridine orange leukocyte staining (AOLS). In diabetic rats, the rate of leukocyte transmigration into the retinal tissues of live animals was significantly increased, as determined by AOLS. When diabetic animals were treated with daily injections of the VAP-1 inhibitor (0.3 mg/kg), leukocyte transmigration rate was significantly reduced (P < 0.05). However, firm adhesion of leukocytes in diabetic animals treated with the inhibitor did not differ significantly from vehicle-treated diabetic controls. This work provides evidence for an important role of VAP-1 in the recruitment of leukocyte to the retina in experimental DR. Our results reveal the critical contribution of VAP-1 to leukocyte transmigration, with little impact on firm leukocyte adhesion in the retinas of diabetic animals. VAP-1 inhibition might be beneficial in the treatment of DR.

Original languageEnglish
Pages (from-to)774-781
Number of pages8
JournalExperimental Eye Research
Volume89
Issue number5
DOIs
Publication statusPublished - Nov 1 2009
Externally publishedYes

Fingerprint

Blood Vessels
Retina
Leukocytes
Proteins
Diabetic Retinopathy
Acridine Orange
Staining and Labeling
Injections
Amine Oxidase (Copper-Containing)
Retinal Vessels
Long Evans Rats
Streptozocin
Concanavalin A
Real-Time Polymerase Chain Reaction
Messenger RNA

All Science Journal Classification (ASJC) codes

  • Ophthalmology
  • Sensory Systems
  • Cellular and Molecular Neuroscience

Cite this

Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes. / Noda, Kousuke; nakao, shintaro; Zandi, Souska; Engelstädter, Verena; Mashima, Yukihiko; Hafezi-Moghadam, Ali.

In: Experimental Eye Research, Vol. 89, No. 5, 01.11.2009, p. 774-781.

Research output: Contribution to journalArticle

Noda, Kousuke ; nakao, shintaro ; Zandi, Souska ; Engelstädter, Verena ; Mashima, Yukihiko ; Hafezi-Moghadam, Ali. / Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes. In: Experimental Eye Research. 2009 ; Vol. 89, No. 5. pp. 774-781.
@article{1656d247ad0645089ddd89c29daefdf7,
title = "Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes",
abstract = "Vascular adhesion protein-1 (VAP-1) is an endothelial adhesion molecule that possesses semicarbazide-sensitive amine oxidase (SSAO) activity and is involved in leukocyte recruitment. Leukocyte adhesion to retinal vessels is a predominant feature of experimentally induced diabetic retinopathy (DR). However, the role of VAP-1 in this process is unknown. Diabetes was induced by i.p. injection of Streptozotocin in Long-Evans rats. The specific inhibitor of VAP-1, UV-002, was administered by daily i.p. injections. The expression of VAP-1 mRNA in the retinal extracts of normal and diabetic animals was measured by real-time quantitative polymerase chain reaction (PCR). Firm leukocyte adhesion was quantified in retinal flatmounts after intravascular staining with concanavalin A (ConA). Leukocyte transmigration rate was quantified by in vivo acridine orange leukocyte staining (AOLS). In diabetic rats, the rate of leukocyte transmigration into the retinal tissues of live animals was significantly increased, as determined by AOLS. When diabetic animals were treated with daily injections of the VAP-1 inhibitor (0.3 mg/kg), leukocyte transmigration rate was significantly reduced (P < 0.05). However, firm adhesion of leukocytes in diabetic animals treated with the inhibitor did not differ significantly from vehicle-treated diabetic controls. This work provides evidence for an important role of VAP-1 in the recruitment of leukocyte to the retina in experimental DR. Our results reveal the critical contribution of VAP-1 to leukocyte transmigration, with little impact on firm leukocyte adhesion in the retinas of diabetic animals. VAP-1 inhibition might be beneficial in the treatment of DR.",
author = "Kousuke Noda and shintaro nakao and Souska Zandi and Verena Engelst{\"a}dter and Yukihiko Mashima and Ali Hafezi-Moghadam",
year = "2009",
month = "11",
day = "1",
doi = "10.1016/j.exer.2009.07.010",
language = "English",
volume = "89",
pages = "774--781",
journal = "Experimental Eye Research",
issn = "0014-4835",
publisher = "Academic Press Inc.",
number = "5",

}

TY - JOUR

T1 - Vascular adhesion protein-1 regulates leukocyte transmigration rate in the retina during diabetes

AU - Noda, Kousuke

AU - nakao, shintaro

AU - Zandi, Souska

AU - Engelstädter, Verena

AU - Mashima, Yukihiko

AU - Hafezi-Moghadam, Ali

PY - 2009/11/1

Y1 - 2009/11/1

N2 - Vascular adhesion protein-1 (VAP-1) is an endothelial adhesion molecule that possesses semicarbazide-sensitive amine oxidase (SSAO) activity and is involved in leukocyte recruitment. Leukocyte adhesion to retinal vessels is a predominant feature of experimentally induced diabetic retinopathy (DR). However, the role of VAP-1 in this process is unknown. Diabetes was induced by i.p. injection of Streptozotocin in Long-Evans rats. The specific inhibitor of VAP-1, UV-002, was administered by daily i.p. injections. The expression of VAP-1 mRNA in the retinal extracts of normal and diabetic animals was measured by real-time quantitative polymerase chain reaction (PCR). Firm leukocyte adhesion was quantified in retinal flatmounts after intravascular staining with concanavalin A (ConA). Leukocyte transmigration rate was quantified by in vivo acridine orange leukocyte staining (AOLS). In diabetic rats, the rate of leukocyte transmigration into the retinal tissues of live animals was significantly increased, as determined by AOLS. When diabetic animals were treated with daily injections of the VAP-1 inhibitor (0.3 mg/kg), leukocyte transmigration rate was significantly reduced (P < 0.05). However, firm adhesion of leukocytes in diabetic animals treated with the inhibitor did not differ significantly from vehicle-treated diabetic controls. This work provides evidence for an important role of VAP-1 in the recruitment of leukocyte to the retina in experimental DR. Our results reveal the critical contribution of VAP-1 to leukocyte transmigration, with little impact on firm leukocyte adhesion in the retinas of diabetic animals. VAP-1 inhibition might be beneficial in the treatment of DR.

AB - Vascular adhesion protein-1 (VAP-1) is an endothelial adhesion molecule that possesses semicarbazide-sensitive amine oxidase (SSAO) activity and is involved in leukocyte recruitment. Leukocyte adhesion to retinal vessels is a predominant feature of experimentally induced diabetic retinopathy (DR). However, the role of VAP-1 in this process is unknown. Diabetes was induced by i.p. injection of Streptozotocin in Long-Evans rats. The specific inhibitor of VAP-1, UV-002, was administered by daily i.p. injections. The expression of VAP-1 mRNA in the retinal extracts of normal and diabetic animals was measured by real-time quantitative polymerase chain reaction (PCR). Firm leukocyte adhesion was quantified in retinal flatmounts after intravascular staining with concanavalin A (ConA). Leukocyte transmigration rate was quantified by in vivo acridine orange leukocyte staining (AOLS). In diabetic rats, the rate of leukocyte transmigration into the retinal tissues of live animals was significantly increased, as determined by AOLS. When diabetic animals were treated with daily injections of the VAP-1 inhibitor (0.3 mg/kg), leukocyte transmigration rate was significantly reduced (P < 0.05). However, firm adhesion of leukocytes in diabetic animals treated with the inhibitor did not differ significantly from vehicle-treated diabetic controls. This work provides evidence for an important role of VAP-1 in the recruitment of leukocyte to the retina in experimental DR. Our results reveal the critical contribution of VAP-1 to leukocyte transmigration, with little impact on firm leukocyte adhesion in the retinas of diabetic animals. VAP-1 inhibition might be beneficial in the treatment of DR.

UR - http://www.scopus.com/inward/record.url?scp=70349456530&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=70349456530&partnerID=8YFLogxK

U2 - 10.1016/j.exer.2009.07.010

DO - 10.1016/j.exer.2009.07.010

M3 - Article

C2 - 19635478

AN - SCOPUS:70349456530

VL - 89

SP - 774

EP - 781

JO - Experimental Eye Research

JF - Experimental Eye Research

SN - 0014-4835

IS - 5

ER -